Country: United States
Language: English
Source: NLM (National Library of Medicine)
TINIDAZOLE (UNII: 033KF7V46H) (TINIDAZOLE - UNII:033KF7V46H)
Edenbridge Pharmaceuticals LLC.
Tinidazole
Tinidazole 250 mg
ORAL
PRESCRIPTION DRUG
Tinidazole is indicated for the treatment of trichomoniasis caused by Trichomonas vaginalis . The organism should be identified by appropriate diagnostic procedures. Because trichomoniasis is a sexually transmitted disease with potentially serious sequelae, partners of infected patients should be treated simultaneously in order to prevent re-infection [see Clinical Studies (14.1) ]. Tinidazole is indicated for the treatment of giardiasis caused by Giardia duodenalis (also termed G. lamblia ) in both adults and pediatric patients older than three years of age [see Clinical Studies (14.2) ]. Tinidazole is indicated for the treatment of intestinal amebiasis and amebic liver abscess caused by Entamoeba histolytica in both adults and pediatric patients older than three years of age. It is not indicated in the treatment of asymptomatic cyst passage [see Clinical Studies (14.3, 14.4) ]. Tinidazole is indicated for the treatment of bacterial vaginosis (formerly referred to as Haemophilus vaginitis, Gardnerella vagi
Tinidazole tablets 250 mg are yellow, round, scored tablets with 207 debossed on one side, supplied in bottles with child-resistant caps as: NDC 42799-207-01 Bottle of 40 Tinidazole tablets 500 mg are yellow, oval, scored tablets with 208 debossed on one side, supplied in bottles with child-resistant caps as: NDC 42799-208-01 Bottle of 20 NDC 42799-208-02 Bottle of 60 Storage : Store at controlled room temperature 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [see USP]. Protect contents from light.
Abbreviated New Drug Application
TINIDAZOLE - TINIDAZOLE TABLET EDENBRIDGE PHARMACEUTICALS LLC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION TINIDAZOLE TABLETS FOR ORAL USE THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE TINIDAZOLE TABLETS SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR TINIDAZOLE TABLETS. INITIAL U.S. APPROVAL: 2004 WARNING: POTENTIAL RISK FOR CARCINOGENICITY _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ CARCINOGENICITY HAS BEEN SEEN IN MICE AND RATS TREATED CHRONICALLY WITH METRONIDAZOLE, ANOTHER NITROIMIDAZOLE AGENT (13.1). ALTHOUGH SUCH DATA HAVE NOT BEEN REPORTED FOR TINIDAZOLE, THE TWO DRUGS ARE STRUCTURALLY RELATED AND HAVE SIMILAR BIOLOGIC EFFECTS. LIMIT USE OF TINIDAZOLE TABLETS TO APPROVED INDICATIONS ONLY (1.1, 1.2, 1.3). AVOID CHRONIC USE. (5.1) RECENT MAJOR CHANGES Contraindications (4) 01/2022 INDICATIONS AND USAGE Tinidazole is a nitroimidazole antimicrobial indicated for: Trichomoniasis (1.1) Giardiasis: in patients age 3 and older (1.2) Amebiasis: in patients age 3 and older (1.3) Bacterial Vaginosis: in non-pregnant, adult women (1.4, 8.1) To reduce the development of drug-resistant bacteria and maintain the effectiveness of tinidazole tablets and other antibacterial drugs, tinidazole tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. (1.5) DOSAGE AND ADMINISTRATION Trichomoniasis: a single 2 g oral dose taken with food. Treat sexual partners with the same dose and at the same time (2.3) Giardiasis: Adults: a single 2 g dose taken with food. Pediatric patients older than three years of age: a single dose of 50 mg/kg (up to 2 g) with food (2.4) Amebiasis, _Intestinal_: Adults: 2 g per day for 3 days with food. Pediatric patients older than three years of age: 50 mg/kg/day (up to 2 g per day) for 3 days with food (2.5). _Amebic liver abscess_: Adults: 2 g per day for 3-5 days with food. Pediatric patients older than three years of age: 50 mg/kg/day (up to 2 g per day) for 3-5 days with food Read the complete document